Simplex Trading
ITOS

Simplex Trading’s iTeos Therapeutics ITOS Stock Holding History

Simplex Trading’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-103,212
Closed -$1.03M – 9510
2025
Q2 		$1.03M Buy
+103,212
New +$831K ﹤0.01% 2746
2025
Q1 		– Sell
-6,070
Closed -$44.6K – 9038
2024
Q4 		$46K Buy
+6,070
New +$52.2K ﹤0.01% 5964
2024
Q3 		– Sell
-16,083
Closed -$245K – 8998
2024
Q2 		$238K Buy
+16,083
New +$230K ﹤0.01% 4493
2024
Q1 		– Sell
-6,426
Closed -$70K – 9323
2023
Q4 		$70K Buy
+6,426
New +$63.7K ﹤0.01% 5749
2023
Q3 		– Sell
-11,503
Closed -$147K – 9200
2023
Q2 		$152K Buy
11,503
+9,463
+464% +$135K ﹤0.01% 4610
2023
Q1 		$27K Sell
2,040
-383
-16% -$6.86K ﹤0.01% 6592
2022
Q4 		$47K Buy
2,423
+2,351
+3,265% +$45.9K ﹤0.01% 5964
2022
Q3 		$1K Sell
72
-11,133
-99% -$256K ﹤0.01% 9555
2022
Q2 		$230K Buy
+11,205
New +$266K ﹤0.01% 4438

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Simplex Trading's ITOS Position: Q3 2025 in Review

Simplex Trading sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 103,212 shares — an estimated $1.03M sold.

Simplex Trading first reported a position in ITOS in Q2 2022 and held it in 9 quarters. The position peaked at $1.03M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Simplex Trading reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 103,212 iTeos Therapeutics shares in Q3 2025, an estimated $1.03M.
  • Simplex Trading first reported a position in iTeos Therapeutics in Q2 2022 and held it in 9 quarters.
  • Simplex Trading's iTeos Therapeutics position peaked at $1.03M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.